Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation (Q44905175)

7 December 2017

Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation (English)

1 reference

7 December 2017

0 references

invasive aspergillosis

1 reference

4

1 reference

7 December 2017

5

1 reference

7 December 2017

Thursky K

1

1 reference

7 December 2017

Byrnes G

series ordinal

2

1 reference

7 December 2017

Grigg A

series ordinal

3

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

Bone Marrow Transplantation

7 December 2017

1 reference

7 December 2017

34

1 reference

7 December 2017

2

1 reference

7 December 2017

115-121

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704543

7 December 2017

0 references

cites work

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

Invasive mold infections in allogeneic bone marrow transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

Bone-marrow transplantation (second of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

Bone-marrow transplantation (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

Definitions of cytomegalovirus infection and disease in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

Immunosuppressive effects of ganciclovir on in vitro lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

7 January 2021

Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

7 January 2021

Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

7 January 2021

A study of the pharmacokinetics, antiviral activity, and tolerability of oral ganciclovir for CMV prophylaxis in marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

7 January 2021

Risk of infectious complications in patients taking glucocorticosteroids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

7 January 2021

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

7 January 2021

Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704543

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704543

1 reference

Dimensions Publication ID

7 December 2017

0 references

1 reference